LifeMD, Inc. (LFMD)
NASDAQ: LFMD · Real-Time Price · USD
3.900
-0.190 (-4.65%)
At close: Mar 20, 2026, 4:00 PM EDT
3.850
-0.050 (-1.28%)
After-hours: Mar 20, 2026, 7:10 PM EDT

LifeMD Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Net Income
31.24-41.72-17.84-45.02-61.32
Depreciation & Amortization
7.316.196.63.770.87
Stock-Based Compensation
10.512.2312.4913.7312.07
Other Adjustments
2.351.762.666.136.17
Change in Receivables
1.15-4.49-2.44-2.190.02
Changes in Inventories
0.02-0.710.41-2.18-0.41
Changes in Accounts Payable
3.244.180.981.25-0.89
Changes in Accrued Expenses
-5.7810.764.68-1.319.86
Changes in Unearned Revenue
-6.299.833.284.050.58
Changes in Other Operating Activities
6.010.94-1.99-1.16-0.03
Operating Cash Flow
10.3531.888.82-22.94-33.09
Operating Cash Flow Growth
-67.52%261.40%---
Capital Expenditures
-1.87-1.46-0.2-0.37-0.25
Purchases of Intangible Assets
-7.65-6.74-8.53-12.53-3.15
Payments for Business Acquisitions
----1.01-
Other Investing Activities
16.43-3.33---
Investing Cash Flow
6.91-11.54-8.73-13.91-3.4
Long-Term Debt Issued
--21.812.9115.96
Long-Term Debt Repaid
-18.72-0.33-5.14-0.17-16.49
Net Long-Term Debt Issued (Repaid)
-18.72-0.3316.672.74-0.53
Issuance of Common Stock
9.190.1216.30.1315.14
Net Common Stock Issued (Repurchased)
9.190.1216.30.1315.14
Issuance of Preferred Stock
----55.34
Net Preferred Stock Issued (Repurchased)
----55.34
Preferred Share Dividends Paid
-3.11-3.11-3.11-3.11-0.87
Other Financing Activities
-0.77-0.81-0.76-0.29-0.44
Financing Cash Flow
-13.41-4.1229.1-0.5368.64
Net Cash Flow
1.781.8629.19-37.3732.15
Free Cash Flow
8.4830.418.62-23.3-33.33
Free Cash Flow Growth
-72.11%252.97%---
FCF Margin
4.37%19.64%5.65%-19.58%-35.89%
Free Cash Flow Per Share
0.190.740.25-0.75-1.23
Levered Free Cash Flow
-4.834.876.72-41.86-52.56
Unlevered Free Cash Flow
-5.068.77-1.1-39.75-44.57
Updated Dec 31, 2025. Data Source: Fiscal.ai. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q